Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in ER+/HER2− Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Biomarkers of response and resistance to palbociclib plus letrozole in patients with ER+/HER2- breast cancer
Clin. Cancer Res 2021 Oct 13;[EPub Ahead of Print], M Dowsett, L Kilburn, MF Rimawi, CK Osborne, K Pogue-Geile, Y Liu, SA Jacobs, M Finnigan, S Puhalla, A Dodson, V Martins, M Cheang, S Perry, C Holcombe, NC Turner, C Swift, JM Bliss, S JohnstonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.